Proteo, Inc. (OTCMKTS:PTEO – Get Free Report)’s share price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.09 and traded as low as $0.09. Proteo shares last traded at $0.09, with a volume of 0 shares.
Proteo Stock Performance
The business has a fifty day simple moving average of $0.09 and a two-hundred day simple moving average of $0.09.
Proteo Company Profile
Proteo, Inc, a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The company focuses on the development of pharmaceuticals based on Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands for use in the treatment of post-surgery damage to tissue; complications resulting from organ transplantation; pulmonary hypertension; and injuries caused by accidents, cardiac infarction, and other diseases.
Recommended Stories
- Five stocks we like better than Proteo
- What is a Secondary Public Offering? What Investors Need to Know
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Value Stocks You Can Buy Before They Become Big
- Following Congress Stock Trades
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Proteo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteo and related companies with MarketBeat.com's FREE daily email newsletter.
